Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianyi Cen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|April 16, 2026
PLAP Targeted Antibody-Radionuclide Conjugate for Theranostics in Pancreatic CancerYanzhao Liu, Jingyue Gao, Mengning Hu, et al.
Journal of Medicinal Chemistry|March 3, 2026
<sup>89</sup>Zr/<sup>177</sup>Lu-Labeled Radioimmunoconjugates Targeting SORT1 for Cancer TheranosticsJingyue Gao, Tianyi Cen, Junyi Chen, et al.
Theranostics|December 1, 2022
Self-assembly of X-shaped antibody to combine the activity of IgG and IgA for enhanced tumor killingYuexia Liang, Xin Li, Fengping Peng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2022
An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situKai Ye, Fan Li, Ruikun Wang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|April 16, 2026
PLAP Targeted Antibody-Radionuclide Conjugate for Theranostics in Pancreatic CancerYanzhao Liu, Jingyue Gao, Mengning Hu, et al.
Journal of Medicinal Chemistry|March 3, 2026
<sup>89</sup>Zr/<sup>177</sup>Lu-Labeled Radioimmunoconjugates Targeting SORT1 for Cancer TheranosticsJingyue Gao, Tianyi Cen, Junyi Chen, et al.
Theranostics|December 1, 2022
Self-assembly of X-shaped antibody to combine the activity of IgG and IgA for enhanced tumor killingYuexia Liang, Xin Li, Fengping Peng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2022
An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situKai Ye, Fan Li, Ruikun Wang, et al.
Pageof 1